Brief: Rigel Reports Fourth Quarter Results, Provides Business Update
05/03/2024 21:05
March 5 (Reuters) - Rigel Pharmaceuticals Inc RIGL.O :
* RIGEL REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* RIGEL PHARMACEUTICALS INC - QTRLY EARNINGS PER SHARE $
0.00
Source text for Eikon: ID:nPn7XHNzqa
Further company coverage: RIGL.O
Recent news on Rigel Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
Rigel Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Rigel Pharmaceuticals Q2 revenue rises on strong product demand
Brief: Rigel Pharmaceuticals - Appoints Alison L. Hannah As Executive Vice President And Chief Medical Officer Effective July 1, 2026 - SEC Filing
Brief: Rigel Announces Closing Of Licensing Agreement For Veppanu (Vepdegestrant)